Medical Research News

RSS

Sports fans may engage in riskier health related behaviors than non-sports fans

Ball park hot dogs may be putting sports fans at elevated health risk, researchers at UALR -- the University of Arkansas at Little Rock -- said in research presented last week.

16 Nov 2008

No evidence supporting the use of vitamin E and C in the prevention of cancer

The Physicians' Health Study II is a large-scale, long-term, randomized clinical trial that included 14,641 physicians who were at least 50 years old at enrollment.

16 Nov 2008

Microbial population of raw milk found to be more complex than previously thought

Raw milk is illegal in many countries as it can be contaminated with potentially harmful microbes.

16 Nov 2008

Negative thinking may play a bigger role in heart failure than previously thought

Researchers at the University of Kentucky found that patients who had negative thinking patterns, such as thoughts about not being able to justify their own existence, were at higher risk for developing depression.

16 Nov 2008

Nanoparticles may alter cell structure and pose health risks

Nanoparticles that are one milliard of a metre in size are widely used, for example, in cosmetics and food packaging materials.

16 Nov 2008

Discovery of key contributor to Alzheimer's disease process

Walter J. Lukiw, PhD, Associate Professor of Neuroscience and Ophthalmology at LSU Health Sciences Center New Orleans, is the lead author of a paper identifying, for the first time, a specific function of a fragment of ribonucleic acid (RNA), once thought to be no more than a byproduct, in regulating inflammation and the development of Alzheimer's disease.

16 Nov 2008

Higher levels of blood phosphate may be a previously unidentified and modifiable cardiovascular risk factor

Healthy adults with higher levels of phosphate in the blood are more likely to have increased levels of calcium in the coronary arteries-a key indicator of atherosclerosis and future cardiovascular disease risk, reports a study in the February 2009 issue of the Journal of the American Society of Nephrology (JASN).

16 Nov 2008

No clear evidence that depression screening improves cardiovascular patients' health

Results of a new study call into question recent clinical guidelines issued by leading cardiovascular groups, including the American Heart Association, which recommend patients with cardiovascular disease be screened for signs of depression and treated accordingly.

16 Nov 2008

Healthy life expectancy in Europe

Although life expectancy is constantly growing in the countries of the EU, living longer isn't always the same as living well, and knowing to what age someone will live in good health remains a different question altogether.

16 Nov 2008

Potential new therapeutic targets for rejuvenating the aged immune system

In the November 15th issue of G&D, Dr. Kenneth Dorshkind and colleagues at the David Geffen School of Medicine (UCLA) have identified two genes - p16(Ink4a) and Arf - that sensitize lymphoid progenitor cells to the effects of aging, and confer resistance to leukemogenesis.

16 Nov 2008

Gender found to be play important role as a prognostic factor in people diagnosed with lung cancer

Even though some combinations of gender, race and/or marital status can factor into the overall survival of nonoperative non-small cell lung cancer patients, gender is the most significant factor impacting overall survival, according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.

16 Nov 2008

Drug-related preference in cocaine addiction extends to images

When given a choice between viewing pictures of cocaine and a variety of other images, cocaine addicted individuals, as compared to healthy, non-addicted research subjects, show a clear preference for the drug-related images.

16 Nov 2008

Doctors' questions about end-of-life legalities may result in patient pain

When treatment options dwindle or are exhausted, terminally ill-patients often opt for pain management and comfort over life-extending therapies.

16 Nov 2008

Difluoromethylornithine may affect Barrett's esophagus

"While there was a suggestion that difluoromethylornithine (DFMO) may influence the extent of Barrett's dysplasia, this finding is very preliminary and further study of this agent in a larger number of patients is needed," said Frank A. Sinicrope, M.D., professor of medicine and oncology at the Mayo Clinic, Rochester, MN.

16 Nov 2008

Cigarette smoke may reshape the left ventricle

Prolonged exposure to cigarette smoke can increase levels of the stress hormone norepinephrine and enzymes in the heart that have the potential to reshape the left ventricle, according to new research at the University of Illinois at Chicago.

16 Nov 2008

Traditional chemotherapy agents with targeted therapies improves survival in advance-stage lung cancer

The combination of traditional chemotherapy agents with targeted therapies called monoclonal antibodies showed no safety concerns and improved survival in patients with advanced non-small cell lung cancer according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.

16 Nov 2008

Breast and prostate cancer treatment may result in bone loss

A new cross-Canada study has found that breast and prostate cancer treatment can foster bone loss.

16 Nov 2008

Calcium may only protect against colorectal cancer in presence of magnesium

High magnesium intake has been associated with low risk of colorectal cancer. Americans have similar average magnesium intake as East Asian populations. If that were all that were involved, observers might expect both groups to have similar risk for colorectal cancer.

16 Nov 2008

Alzheimer's gene apolipoprotein E4 slows export of amyloid-beta

The only known genetic risk factor for Alzheimer's disease slows down the brain's ability to export a toxic protein known as amyloid-beta that is central to the damage the disease causes, scientists have found.

16 Nov 2008

Advanced lung cancer patients see improved, progression-free survival

Patients with advanced non-small cell lung cancer whose disease has progressed following chemotherapy have a higher rate of tumor shrinkage and a longer interval before cancer progression when bevacizumab is added to standard second-line erlotinib therapy, according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.

16 Nov 2008